IRA C. SPECTORCEO, CO-FOUNDER
PhD, University of Medicine & Dentistry, NJ (Rutgers), MBA,
Drexel University
Wyeth, Pfizer, Allergan, ICON;
experienced drug developer on 34 NDAs and co-founder of
4 prior startups, 30 years of experience
MARK FEITELSONCSO, CO-FOUNDER
PhD, Immunovirology, UCLA Geffen Medical School;
Co-inventor, Professor at Temple University
World-class
expert in liver disease; advisor to Chiron Diagnostics,
Biogen, Immune Response Corp, Pharmasset &
amp; QuadPharma, Ribozyme, Maxygen, USINO, and Theravectys, 35 years of experience
ALLA ARZUMANYANCDO, CO-FOUNDER
PhD, Biotechnology, Yerevan University, Armenia;
Co-inventor; Assistant Professor at Temple and
Jefferson University;
Eexpert in stem cell cancers,
HBV and GI microbiome, worked with HEC
(Sunshine Lake Pharma Co.), Theravectys, and
ThirdLaw, 25 years of experience
MBA, Operations Management, University of Delaware. B.S, Molecular and Cell Biology, Pennsylvania State Univeristy.
Experienced executive at big pharma Astra-Zeneca, Wyeth/Pfizer, Medtronic and startups Intrexon, Taiho Oncology, Iterum Therapeutics, Intercept Pharmaceuticals; hands-on clinical operations expert with numerous drug approvals, 25 years of experience
Shawn O’BrienChairman
, Western University
Serial life sciences entrepreneur; Founder, Consultant, C-Suite and Board positions at multiple startups including: Genomind, Cipher Pharmaceuticals, Melanovus Oncology, Cyrano Nasal Sciences Altherx, Solstice Neurosciences; and Executive postitions at AstraZeneca
MBA, The Wharton School, Unversity of Pennsylvania, BA Economics, Princeton University.
Board Member, Advisor, C-Level Life Science and Investment Banking Executive. Biotechnology Startup Veteran; South Rampart Pharma, Virtuviae, BCI Life Sciences, Sharp Edge Labs, Emmaus Life Sciences, Sanuthera, Tyme Technolgies, BeyondSpring, Pharmaceuticals, Motif Bio, Neostem, Hemispherx Biopharma, StemCyte, Locus Pharmaceuticals. Investmetn Banker; Legg Mason, Lehman Brothers
